Thermostable Vaccine Market
Updated Date: 03 August 2026   |   Report Code: 5117

Thermostable Vaccine Market Growth, Innovations and Market Size Forecast 2035

According to our projections, the thermostable vaccine sector is expected to grow from USD 9.27 billion in 2025 to USD 19.05 billion by 2035, reflecting a CAGR of 7.47%. The thermostable vaccine market is growing fast, driven by the need for heat-resistant vaccines that don’t require cold storage. These innovative vaccines improve access in remote areas, making immunization safer and more reliable worldwide.

Last Updated : 03 August 2026 Category: Biotechnology Insight Code: 5117 Format: PDF / PPT / Excel

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Thermostable Vaccine Market Assessment

  • Overview
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs
  • Global Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Thermostable Vaccine Market Assessment

  • Overview
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • North America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Europe Thermostable Vaccine Market Assessment

  • Overview
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Europe Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Asia Pacific Thermostable Vaccine Market Assessment

  • Overview
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Asia Pacific Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Latin America Thermostable Vaccine Market Assessment

  • Overview
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Latin America Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Middle East and Africa Thermostable Vaccine Market Assessment

  • Overview
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Vaccine Type (2021 – 2033)
    • Viral Vaccine
    • Bacterial Vaccine
    • Parasitic Vaccine
    • Other Vaccines
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Application (2021 – 2033)
    • Human Health
    • Animal Health
  • Middle East and Africa Thermostable Vaccine Market Size Value (US$) and Volume (Million Tons), by Development Stage (2021 – 2033)
    • Preclinical Research
    • Clinical Trials
    • Approved Drugs

Company Profiles

  • Serum Institute of India
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Sanofi
  • GSK
  • Hilleman Laboratories
  • Soligenix

Conclusion & Recommendations

FAQ's

Answer : The thermostable vaccine market is valued at USD 9.96 billion in 2026 and is projected to nearly double to USD 19.05 billion by 2035, growing at a steady 7.47% CAGR.

Answer : The biggest trend is moving beyond cold-chain dependency. Advances in freeze-dried formulations, heat-stable mRNA vaccines, and room-temperature storage are reshaping vaccine logistics.

Answer : Major players like Serum Institute of India, Sanofi, GSK, Hilleman Laboratories, and Soligenix are at the forefront.

Meet the Team

Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.

Learn more about Payal Rabde

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar